There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The purpose of this study was to evaluate the activity and toxicity of carboplatin
and paclitaxel combination in advanced or recurrent endometrial carcinoma.
[1
]
Second Department of Internal Medicine, Propaedeutic, Oncology Section, University
of Athens, Attikon University Hospital, Haidari, 1 Rimini, Athens, Greece. pectasid@otenet.gr